Pharmaceutical companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Roivant Sciences leads the 50 pharmaceutical companies ranked by P/S ratio, at 3382, ahead of Dianthus Therapeutics (2408) and Protagonist Therapeutics (179). Figures as of 18 Nov 2026, 19:01 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- First
- Roivant Sciences3382
- Median
- 6.9
- Combined market value
- THB 172.54T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | P/S ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Roivant SciencesROIV · Health Care | 3382 | THB 948.3B | THB 1,308.77 | 0.41% down | 90% up | ||
| 2 | Dianthus TherapeuticsDNTH · Health Care | 2408 | THB 166.5B | THB 2,955.86 | 0.10% up | 113% up | ||
| 3 | Protagonist TherapeuticsPTGX · Health Care | 179 | THB 279B | THB 4,273.97 | 0.98% up | 46% up | ||
| 4 | CytokineticsCYTK · Health Care | 81.4 | THB 243.2B | THB 1,745.54 | 0.45% down | 20% down | ||
| 5 | Rhythm PharmaceuticalsRYTM · Health Care | 44.1 | THB 284.4B | THB 4,102.18 | 3.62% up | 13% up | ||
| 6 | InsmedINSM · Health Care | 43.6 | THB 897.1B | THB 4,089.45 | 1.15% down | 40% down | ||
| 7 | BridgeBio PharmaBBIO · Health Care | 30.3 | THB 516.4B | THB 2,650.82 | 1.67% up | 17% up | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 22.5 | THB 205B | THB 10,249.68 | 2.76% up | 43% up | ||
| 9 | Ascendis PharmaASND · Health Care | 22.2 | THB 603.2B | THB 9,195.36 | 0.13% down | 28% up | ||
| 10 | Eli LillyLLY · Health Care | 19.0 | THB 42.1T | THB 47,261.80 | 1.66% down | 35% up | ||
| 11 | Royalty PharmaRPRX · Health Care | 16.8 | THB 1.35T | THB 2,356.47 | 1.06% up | 78% up | ||
| 12 | TG TherapeuticsTGTX · Health Care | 16.2 | THB 339.1B | THB 2,243.42 | 5.37% up | 107% up | ||
| 13 | Mirum PharmaceuticalsMIRM · Health Care | 11.5 | THB 204.2B | THB 3,128.49 | 0.22% up | 31% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | 11.4 | THB 4.64T | THB 18,293.28 | 0.87% up | 27% up | ||
| 15 | Axsome TherapeuticsAXSM · Health Care | 11.1 | THB 240.4B | THB 4,570.69 | 0.97% down | 7% down | ||
| 16 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | THB 253.8B | THB 3,230.34 | 0.04% up | 126% up | ||
| 17 | Travere TherapeuticsTVTX · Health Care | 10.0 | THB 166.5B | THB 1,734.51 | 0.02% down | 44% up | ||
| 18 | Madrigal PharmaceuticalsMDGL · Health Care | 9.8 | THB 320B | THB 13,775.89 | 3.84% down | 24% down | ||
| 19 | Corcept TherapeuticsCORT · Health Care | 9.8 | THB 252.8B | THB 2,310.13 | 2.89% down | 8% down | ||
| 20 | BeOne MedicinesONC · Health Care | 8.7 | THB 1.57T | THB 13,745.00 | 2.03% down | 17% up | ||
| 21 | GenmabGMAB · Health Care | 8.5 | THB 1.08T | THB 1,747.75 | 0.92% down | 70% up | ||
| 22 | AbbVieABBV · Health Care | 8.3 | THB 17.22T | THB 9,742.80 | 2.00% down | 26% up | ||
| 23 | United TherapeuticsUTHR · Health Care | 7.8 | THB 841.3B | THB 19,754.83 | 0.38% down | 23% up | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | THB 208.2B | THB 1,472.58 | 0.90% up | 10% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | 7.0 | THB 22.45T | THB 9,327.42 | 1.42% down | 38% up | ||
| 26 | Regeneron PharmaceuticalsREGN · Health Care | 6.8 | THB 3.33T | THB 32,190.37 | 1.00% down | 36% up | ||
| 27 | Alnylam PharmaceuticalsALNY · Health Care | 5.4 | THB 684.1B | THB 5,107.27 | 3.88% down | 66% down | ||
| 28 | NovartisNVS · Health Care | 5.4 | THB 9.99T | THB 5,289.24 | 2.10% down | 25% up | ||
| 29 | AlkermesALKS · Health Care | 5.3 | THB 267.5B | THB 1,591.75 | 3.16% up | 58% up | ||
| 30 | Merck & CoMRK · Health Care | 5.2 | THB 11.56T | THB 4,689.24 | 3.66% down | 51% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | 4.9 | THB 158.1B | THB 949.24 | 3.71% up | 64% down | ||
| 32 | AstraZenecaAZN · Health Care | 4.7 | THB 9.44T | THB 6,088.93 | 1.60% down | 2% up | ||
| 33 | Abbott LaboratoriesABT · Health Care | 4.1 | THB 6.15T | THB 3,548.11 | 0.19% down | 17% down | ||
| 34 | Novo NordiskNVO · Health Care | 3.8 | THB 5.91T | THB 1,341.36 | 2.92% down | 17% down | ||
| 35 | Jazz PharmaceuticalsJAZZ · Health Care | 3.7 | THB 538.1B | THB 8,383.10 | 2.58% up | 37% up | ||
| 36 | ZoetisZTS · Health Care | 3.7 | THB 1.18T | THB 2,894.24 | 2.12% up | 29% down | ||
| 37 | BioMarin PharmaceuticalBMRN · Health Care | 3.6 | THB 399.1B | THB 2,060.43 | 3.73% up | 11% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | THB 425.3B | THB 510.10 | 1.59% up | 5% up | ||
| 39 | Legend BiotechLEGN · Health Care | 3.1 | THB 106.8B | THB 550.67 | 0.68% up | 42% down | ||
| 40 | PTC TherapeuticsPTCT · Health Care | 2.9 | THB 171B | THB 2,047.25 | 0.10% down | 20% down | ||
| 41 | Elanco Animal HealthELAN · Health Care | 2.9 | THB 456.3B | THB 912.92 | 4.02% up | 20% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.8 | THB 1.67T | THB 1,428.96 | 1.24% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.6 | THB 5.45T | THB 955.52 | 1.14% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.5 | THB 4.17T | THB 2,038.36 | 2.14% down | 34% up | ||
| 45 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | THB 260.7B | THB 748.26 | 4.36% up | 83% up | ||
| 46 | Takeda PharmaceuticalTAK · Health Care | 2.4 | THB 2.32T | THB 725.17 | 1.29% down | 54% up | ||
| 47 | SanofiSNY · Health Care | 2.3 | THB 3.85T | THB 1,604.48 | 0.57% down | 4% down | ||
| 48 | GSKGSK · Health Care | 2.3 | THB 3.32T | THB 1,654.55 | 1.03% down | 6% up | ||
| 49 | ViatrisVTRS · Health Care | 1.7 | THB 806.1B | THB 703.10 | 1.27% up | 96% up | ||
| 50 | GrifolsGRFS · Health Care | 0.7 | THB 195.2B | THB 286.88 | 2.09% down | 1% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9500 THB). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by P/S ratio?
Roivant Sciences (3382), Dianthus Therapeutics (2408) and Protagonist Therapeutics (179) are the top three of the 50 pharmaceutical companies ranked by P/S ratio as of 18 Nov 2026, 19:01 UTC.
How many pharmaceutical companies are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 50 pharmaceutical companies ranked by P/S ratio have a combined market value of THB 172.54T as of 18 Nov 2026, 19:01 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.